Genetic studies of type 1 diabetes (T1D) have been advanced by comparative analysis of multiple susceptible and resistant rat strains with a permissive class II MHC haplotype, RT1 u . LEW.1WR1 (but not resistant LEW.1W or WF) rats are susceptible to T1D induced by a TLR3 agonist polyinosinic:polycytidylic acid followed by infection with parvovirus. We have mapped genetic loci for virus-induced T1D susceptibility, identifying a major susceptibility locus (Iddm37) near the MHC. The Iddm37 homologs on mouse and human chromosomes are also diabetes linked. We report that a major effect gene within Iddm37 is diubiquitin (Ubd). Gene expression profiling of pancreatic lymph nodes in susceptible and resistant rats during disease induction showed differences in Ubd transcript abundance. The LEW.1WR1 Ubd promoter allele leads to higher inducible levels of UBD than that of LEW.1W or WF. Using zinc-finger nucleases , we deleted a segment of the LEW.1WR1 Ubd gene and eliminated its expression. UBD-deficient rats show substantially reduced diabetes after viral infection. Complementary studies show that there may be another diabetes gene in addition to Ubd in the Iddm37 interval. These data prove that Ubd is a diabetes susceptibility gene, providing insight into the interplay of multiple genes and environmental factors in T1D susceptibility.
INTRODUCTION
Type 1 diabetes (T1D) afflicts a million Americans 1 causing numerous complications and shortening life. It is a polygenic, T-cell-mediated disease that results from the interaction of multiple gene variants 2 and environmental factors. 3 There are, to date, no approved methods for preventing or abrogating the disease. T1D susceptibility has a strong genetic linkage to the major histocompatibility complex (MHC) in all tested species. Genome-wide association studies (GWAS) have identified more than 50 non-MHC T1D candidates, many of which are classified in gene ontology analyses as members of 'immune system process'. 4 Each of these loci have only a modest effect (odds ratio o1.5), although the concatenation of risk alleles may amplify the risk. 5 Many GWAS candidate genes are just those candidates with the informative single nucleotide polymorphisms located nearby in noncoding regions with no clear function. 6 It is not always possible to deduce from human allelic variation in GWAS regions the actual genomic change that influences risk or the level at which the environment interacts with the genome.
T1D in humans remains quite perplexing in other ways. T1D is becoming more common, for unknown reasons, and it is suggested that virus exposure elicits T1D or, paradoxically, protects against it. Evidence that human viral infections are protective against autoimmunity (that is, hygiene hypothesis) is correlative. 7, 8 Significant evidence has mounted linking enteroviral infections to the initiation of T1D 9 and to progression from islet autoimmunity to overt T1D. 10, 11 Animal models are invaluable in sorting out the mechanism by which GWAS genes could influence complex diseases such as autoimmune diabetes. A recent example is the discovery that the GWAS gene encoding the transcription factor BACH2 has a critical role in mouse regulatory T-cell (Treg) function, 12 known to be compromised in nonobese diabetic (NOD) mice. 13 They are potentially invaluable for analyzing the interaction of genes and environmental perturbants, especially viral infection. Both NOD mice and various rat strains have been used for this purpose. The NOD mouse model has not been helpful in this regard [14] [15] [16] because most viral infections prevent T1D in this animal. In contrast, we have documented that the growing evidence for environmental triggers of the disease can be modeled in a number of rat strains, allowing for the dissection of specific geneenvironment collaborations in initiating diabetes. 17, 18 Rats have been a good (albeit negative) predictor of human clinical T1D trial outcomes (reviewed in Mordes et al. 17, 18 ). The need for new clinical strategies is pressing. With the exception of generalized immunosuppression, 19 which is unacceptably toxic, 20 no preventive intervention has achieved clinical success. 21 To map T1D genes and their relation to environmental factors, we have used rat models of the disease. The LEW.1WR1 rat develops spontaneous diabetes at a low rate but is also very susceptible to the induction of diabetes using a small, nondiabetogenic priming dose of the TLR3 agonist polyinosinic:polycytidylic acid (poly I:C) followed by infection with Kilham rat virus (KRV); it has been shown that KRV does not directly infect the pancreas and its role in the breakdown of self-tolerance is not completely understood. 22, 23 With this treatment, rats develop symptoms of diabetes 10-18 days after infection.
As is true for humans and the NOD mice, T1D in rats is strongly associated with a permissive class II MHC haplotype. In the rat, the MHC locus is designated RT1 and the permissive class II haplotype is designated RT1-B/D u . 24 The RT1-B locus is homologous to human HLA-DQ and RT1-D to HLA-DR. In rats, the two class II loci are in strong linkage disequilibrium, and this is reflected in the 'B/D' nomenclature. In addition, a previous genome-wide linkage study 25 was used to identify regions of the rat genome that control T1D due to virus exposure. In this linkage study, (LEW.1WR1 Â WF) F2 animals were used to map two major quantitative trait loci, both derived from LEW.1WR1, that promote diabetes susceptibility in rats. In addition to an established susceptibility locus (Iddm14), [26] [27] [28] a new locus (Iddm37) near the MHC on chromosome 4 was found to be a major determinant of T1D disease susceptibility virus-induced T1D. 25 Interestingly, Iddm37 homologs on mouse 29 and human chromosomes 30, 31 are also linked to T1D.
In the present study, we took advantage of congenic strains that are closely related to LEW.1WR1 and informative for the Iddm37 interval. The LEW.1WR1 rat was generated from two LEW MHC congenics, LEW.1W and LEW.1A (Figure 1 ). On the basis of their genotypes, we predicted that both parental strain rats would be resistant to induction of diabetes by KRV þ poly I:C but for different reasons. LEW.1W has the permissive class II MHC (RT1-B/D u ) but not the permissive Iddm37, whereas LEW.1A has the permissive Iddm37 but a nonpermissive class II region (RT1-B/D a ). 32, 33 LEW.1WR1 rats bear RT1-D/B u (MHC class II) and a recombination distal to the Iddm37 interval and are susceptible.
We confirmed this hypothesis and proceeded to positional gene identification for Iddm37 using the LEW.1WR1 and LEW.1W strains. To do so, we performed gene expression studies of the genes in the interval, and identified two genes for further study. The strain distribution pattern of sequence polymorphisms and expression patterns of one of these genes, diubiquitin (Ubd), closely resembled the strain distribution pattern of virus-induced diabetes in rats. 24 The Ubd gene was then deleted on the LEW.1WR1 background, which resulted in modestly but significantly reduced diabetes incidence, as would be expected of a single gene in the polygenetic context of T1D. To our knowledge, this is the first genetic deletion using zinc-finger nucleases (ZFN) technology of any autoimmune candidate gene in rats.
RESULTS

Susceptibility to KRV-induced T1D in congenic rat strains
We first assessed the susceptibility of three LEW congenic rat strains to virus-induced diabetes. As shown in Figure 2 , we documented diabetes susceptibility in LEW.1WR1 rat and diabetes resistance in LEW.1A rats, which bear the nonpermissive RT1-B/D a haplotype. This experiment also confirmed our prediction that LEW.1W congenic rats, bearing a permissive RT1-B/D u but a resistant haplotype for the Iddm37 interval, are T1D resistant in response to viral infection.
Microarray
There are 370 known genes and gene elements in the Iddm37 region (Rat genome v4, http://genome.ucsc.edu/) and we examined the expression differences for all of them using the Affymetrix RG230 2.0 GeneChip (Affymetrix, Santa Clara, CA, USA). For this experiment, we treated one group of nine LEW.1WR1 rats and two groups of diabetes resistant rats (LEW.1W and WF.Iddm4, nine of each) to induce diabetes. The WF.Iddm4 is a congenic diabetes resistant substrain of the WF rat into which a segment of BBDR rat chromosome 4 was introduced. 34 It is susceptible to diabetes induced by poly I:C but not rat virus. 34 Using these animals, we then examined global transcript levels in pancreatic lymph nodes across three early time points in disease progression (day 0, after poly I:C; day 3, after KRV; and day 5, after KRV). Comparisons were made between LEW.1WR1 and each of the other rat strains. We accepted a false discovery rate of 0.20, to account for the biological diversity among the three replicates each time.
Nine genes within the Iddm37 interval were differentially regulated in the same direction in comparisons of LEW.1WR1 vs LEW.1W and LEW.1WR1 vs WF.Iddm4, as would be expected for an Iddm37 candidate gene. Confirmatory quantitative RT-PCR was conducted for all nine of these genes ( Table 1) . We selected for further study, the two most significantly different genes that were concordant and different across all time points: UBD and RT1-N1 (Table 1 ). RT1-N1 is an MHC class Ib gene (http://rgd.mcw.edu/ rgdweb/report/gene/main.html?id=3498). Notably, there was an excess of LEW.1WR1 Ubd transcripts, and an excess of LEW.1W RT1-N1 transcripts on day 0, even before the KRV inoculation.
Iddm37 candidate gene strain distribution patterns (SDP)
To determine which of the two genes was the more likely candidate for Iddm37, it was necessary to characterize their alleles and haplotypes in a number of rat strains (that is, to determine their SDP). To obtain an SDP for the RT1-N1 gene, we first identified polymorphic variants between LEW.1W and LEW.1WR1 by sequencing, which identified one synonymous single nucleotide polymorphisms (at nucleotide 2 785 930 on chromosome 20) between LEW.1W and LEW.1WR1 in exon 2 and a second single nucleotide polymorphisms (nucleotide 2 785 102) in the promoter region that distinguishes LEW.1W and WF from LEW.1WR1. We The rat strains show highly significantly different susceptibility to T1D (w 2 ¼ 28.99, Po0.0001). Days PI, days post induction by poly I:C þ KRV. For these studies, a total of 18 LEW.1WR1, 12 LEW.1W and 6 LEW.1A rats were induced for T1D when they reached 28-30 days of age.
also identified a polymorphic repetitive element 115 bp from the TAA-stop site. Strains that carry the RT1 a or RT1 l haplotype (LEW.1WR1, LEW.1A, DA, and LEW) at the RT1-N1 locus have a 35 bp insertion at this repetitive element, whereas rat strains carrying the RT1 u haplotype (WF, LEW.1W and BBDR) were characterized by the absence of this additional 35 bp (Table 2) .
We also used sequencing to characterize the Ubd haplotypes. In our previous report, we presented two haplotypes for the coding region of Ubd. 25 We now report an additional Ubd haplotype for the BBDR rat and several other strains that have been classified for T1D susceptibility 24 (Supplementary Figure 1) . Sequencing the promoters and 5 0 -UTR of Ubd from LEW.1W, LEW, WF and LEW.1WR1 haplotypes revealed two major allelic variants among these strains. There is a polymorphic microsatellite region at -775 relative to the transcriptional start site, and in all the resistant strains, an insertion of 59 nucleotides just upstream of the 5 0 -UTR. This 59-nt insertion is a short interspersed element (B2-SINE) as described by the UCSC database (rat genome v4, genome.ucsc.edu).
The polymorphisms of Ubd-including the SINE-were compiled to make an SDP of Ubd haplotypes for comparison with the SDP for RT1-N1 sequence polymorphisms and the SDP of diabetes susceptibility ( Table 2 ). The results show that RT1-N1 is a less probable candidate gene than Ubd, because BBDR rats do not have the same RT1-N1 allele as LEW.1WR1, yet both are susceptible to virus-induced T1D. The Ubd SINE, on the other hand, has an identical SDP for T1D in these rat strains. All the RT1 u rat strains that are diabetes resistant have low Ubd expression, and Ubd is highly expressed (and cytokine inducible 25 ) in both KRV-T1D-susceptible rat strains, whereas RT1-N1 expression is discordant. In addition, no functionally relevant polymorphisms were found in the RT1-N1 sequence between LEW.1W and LEW.1WR1, strengthening the notion that Ubd is the gene that more likely underlies the Iddm37 susceptibility locus.
Ubd promoter polymorphisms control allele-specific Ubd expression The gene expression data showing reduced Ubd gene expression in LEW.1W and WF.Iddm4 rats were not surprising, as we have previously demonstrated that expression of UBD in draining lymph nodes of poly I:C þ KRV inoculated animals is fourfold higher in LEW.1WR1 rats than in WF rats; this difference is even more dramatic in splenocytes. 25 In that study, we proved that this was not due to a deficiency of required inflammatory cytokines, which were expressed at similar levels in both rats, indicating that rats of both strains had comparable cytokine responses to poly I:C and to the KRV infection.
It was important to link the phenotype (low Ubd mRNA expression) to the allelic polymorphism seen in LEW.1W. We analyzed the SINE insertion and the region surrounding it using a program to highlight transcription factor binding sites (Transfac, http://www.gene-regulation.com/index2.html); the result suggested that insertion of the SINE could add new transcription factor binding sites and/or distance native Ubd promoter elements from the transcriptional start site. The contribution of the microsatellite polymorphism in the upstream region of the Ubd promoter, however, was unknown. To distinguish which of the two polymorphic promoter elements is responsible for the UBD expression difference, luciferase reporter vectors were constructed (Supplementary figure 2) comprising each variant region in the promoter from either the LEW.1WR1 or the LEW.1W rat, and measured luciferase expression. When tested in vitro in Huh7 cells, the level of luciferase in cells transfected with the SINE-containing promoter from LEW.1W was significantly lower compared with the level of luciferase driven by the Ubd promoter from LEW.1WR1 (Figure 3 ). The region containing the microsatellite polymorphism Virus-triggered autoimmune diabetes in rats L Cort et al did not drive expression of the reporter (not shown). The transfected cells were also grown in the presence of TNF-a, IFNg or IFN-b, all of which have been demonstrated to induce Ubd transcription in vitro. 35, 36 The results show that the LEW.1WR1 Ubd promoter is highly cytokine-inducible, and the presence of the SINE inhibits cytokine induction of Ubd in LEW.1W (Figure 3 ).
UBD-KO rats
These results suggested but did not prove that expression of Ubd, the top candidate for Iddm37, is a modifier of diabetes susceptibility. To test this hypothesis, we targeted Ubd for genetic deletion in LEW.1WR1 rats. Nucleotide sequencing of tail DNA for heterozygosity at the Ubd locus identified a number of candidate founder rats. One founder (LEW.1WR1-Ubd emUmass or UBD-KO) had a 65-base pair deletion of intron 1/exon 2 that eliminates a splice acceptor site ( Supplementary Figure 3) . Progeny from this founder were crossed to produce heterozygous and homozygous UBD-KO rats for comparison with the wild-type (WT) rats on the LEW.1WR1
background. Rats bearing a homozygous deletion of Ubd were viable and expressed no Ubd transcripts in their spleens (data not shown).
Absence of UBD expression reduces susceptibility to virus-induced T1D in LEW.1WR1 rats
We first compared diabetes susceptibility of LEW.1WR1 rats with that of LEW.1WR1 rats with either heterozygous or homozygous deletion of Ubd. As shown in Figure 4 , overall diabetes frequency in WT LEW.1WR1 rats was highest of the three strains, LEW.1WR1-UBD-KO heterozygotes were less susceptible, and the homozygous LEW.1WR1-UBD-KO rats were the least susceptible. The diabetes-free survival proportions are significantly increased in the heterozygotes (13%) and homozygotes (26%) (w 2 test for trend, P ¼ 0.016, Figure 4b ). Latency to onset in rats that became diabetic was similar in the three groups, and for this reason, the Kaplan-Meier plot (Figure 4a ) of the three groups showed a trend that did not reach statistical significance (Po0.2).
Genetic complementation enhances susceptibility of resistant LEW.1W rats to virus-induced T1D One advantage of using the knockout strategy is that the resulting genetically deficient animals can be bred to a strain bearing a putative defective allele to determine if the deleted allele is identical to the defective one. We hypothesize that LEW.1W carries a defective allele of the Ubd gene because we have shown that it cannot be upregulated normally by cytokines and thus is likely to be hypofunctional in the setting of diabetes. To test this hypothesis, we bred LEW.1W rats to heterozygous LEW.1WR1-UBD-KO rats. If Iddm37 is Ubd, then the Ubd-KO-bearing chromosome from the heterozygous parent will not be able to 'complement' the defective LEW.1W Iddm37 allele, and the hybrid (LEW.1W/LEW.1WR1-UBD-KO) rat will remain resistant to diabetes. If Iddm37 is not Ubd, the 'authentic' Iddm37 gene on the UBD-KO chromosome (derived from LEW.1WR1) will bear a susceptible complementing allele for Iddm37, and the hybrid will be as susceptible as the normal F1-hybrid between LEW.1W and LEW1.WR1. The other WT chromosome from the LEW.1WR1-UBD-KO heterozygous parent serves as an internal control for the experiment, providing a confirming comparison for the known T1D susceptibility of Iddm37 heterozygotes. 25 The results of the complementation experiment were revealing. The UBD-KO showed a significant effect on the LEW.1W background (Kaplan-Meier statistic, P ¼ 0.013; Figure 5a ). The hybrid rat bearing a deletion of Ubd on one chromosome and a defective allele from LEW.1W on the other (LEW.1W/LEW.1WR1-UBD-KO) shows greatly increased diabetes-free survival in rats (60%) compared with their WT control, LEW.1W/LEW.1WR1 (25%). This , meaning that the UBD-KO partially complemented the defective allele in LEW.1W. The fact that the LEW.1W defect was partially but not fully complemented by the LEW.1WR1 chromosome carrying the Ubd knockout allele means that Ubd and an additional unidentified gene in the Iddm37 interval both contribute to diabetes. As in the LEW.1WR1 crosses, there is a highly significant difference in incidence in LEW.1W crosses (Figure 5b , w 2 -test for trend, P ¼ 0.0023), but no significant difference in the latency of those rats that become diabetic. Together, the data from the two crosses support a model where the polymorphic haplotypes of Ubd significantly influences the incidence of KRV þ poly I:C-induced diabetes in the rat.
DISCUSSION
Diabetes-susceptible rat strains have very high fidelity to the clinical pathology seen in human autoimmune diabetes. This is especially true for testing the gene-environment interactions that induce the disease. Such interactions are difficult to discern in the NOD mouse model of T1D because all environmental perturbations including viral infections that have been studied uniformly prevent the disease. 17, 18, 37 The recently developed technologies that allow targeting of genes for deletion in the rat [38] [39] [40] [41] have made this species exceptionally useful for the dissection of the genetic requirements for diabetes susceptibility. In this report, we have taken the diabetes quantitative trait loci Iddm37 from a map position on the proximal arm of chromosome 20 that encompasses about 4 Mb 25 to a lead candidate gene, Ubd. Deletion of the Ubd gene substantially and significantly reduced the incidence, but not the latency, of T1D in UBD-KO rats as compared with their respective WT controls in two large cohorts of rats. This is to our knowledge, the first successful genetic knockout of a rat autoimmunity gene.
In identifying this gene, we have uncovered a new pathway relevant to autoimmune disease susceptibility. UBD is much more highly expressed in the LEW.1WR1 rat than in the resistant strains. The SINEs in the UBD promoter in resistant strains likely plays a role as a transcriptional repressor of UBD. It has been shown that SINEs s can influence the expression of nearby genes 42, 43 although the repressive mechanism in the Ubd promoter is unknown. The link between higher UBD expression and higher disease incidence suggests that UBD could be required for the recognition or processing of viral or self-antigens, or for activating T cells that recognize them. Although UBD, a diubiquitin with ubiquitin-like properties, is likely expressed in pancreas, in antigen-presenting cells, B cells and T cells in rats, humans and mice, 25, [44] [45] [46] its Comparison of diabetes-free survival among the same three rat strains. The difference due to Ubd genotype is significant (w 2 ¼ 9.289, P ¼ 0.0023). For these studies, 6 LEW.1W, 11 heterozygous LEW.1WR1Ubd-KO /LEW.1W and 12 heterozygous LEW.1WR1/LEW.1W littermate rats were studied as litters reached 28-30 days of age.
Virus-triggered autoimmune diabetes in rats L Cort et al functional importance in these tissues has not yet been defined. The human homolog of Ubd is called FAT10, for HLA-F-adjacent transcript number 10. It is known that dendritic cell maturation induces FAT10 in human cells. 47, 48 In addition, CD40L-CD40 ligation, TLR agonists such as LPS or poly I:C and some cytokines cause upregulation of FAT10 in dendritic cell. 47 FAT10:protein conjugates undergo rapid proteasome-dependent degradation in dendritic cells, 49 supporting a potential role for UBD in antigen presentation. FAT10/UBD is also associated with resistance to apoptosis in lymphocytes. 35, 45 It is of interest that our complementation data suggest further that there is a second gene in addition to Ubd in the Iddm37 interval. 50, 51 When we analyze the entire set of rat UBD-KO crosses tested for T1D susceptibility, there is a highly significant trend associated with both the alleles of Ubd or the absence of Ubd and with a second, as yet unidentified gene ('gene 2') ( Table 3 , w 2 -test for trend, Po0.0001). If Ubd were the sole gene underlying the effect of Iddm37, the complementation experiment would have shown complete resistance in the LEW.1WR1-KO/LEW.1W hybrid rat, instead of the observed 60% resistance (line 4 of Table 3 ). This second gene is being sought in our congenic animals. These data indicate additivity of multiple genes, each of relatively small effect size, underlying diabetes. This finding will in future studies allow us to analyze in detail T1D susceptibility as a function of the number of susceptible alleles as we have done for Iddm37 (Table 3 ). This combinatorial analysis of genetic elements in the rat is similar to the cumulative genetic risk analysis for human T1D developed by Winkler et al. who were able to predict diabetes risk in the BABY DIAB cohort based on non-HLA-risk allele scores. 5 The rat models we now have will allow us to generate this kind of risk for individual genotypes and apply them to different pathways leading to T1D-viral infection, Treg deficiency and other stressors. This should eventually allow us to enrich the repertoire of candidate interventions for halting the progress to T1D in children at risk.
As an example, the identification of Ubd as a diabetes susceptibility gene should reanimate studies of the role of FAT10/Ubd in children at risk for T1D by virtue of HLA haplotype and family history. The Eisenbarth group has reported linkage to the region containing UBD in their study of Type 1 Diabetes Genetics Consortium (T1DGC) cases and controls. 30, 31, 52 This human research, coupled with our analyses of the relative necessity of Ubd for diabetes induced by virus in rats, leads us to propose that Ubd is a good candidate gene for T1D, but quite possibly only in the setting of an environmental perturbant. Our studies clearly demonstrate the interaction of genetic requirements of the disease and environmental factors, and comparable analyses may be necessary to achieve a more complete understanding of the origins of T1D in human populations.
MATERIALS AND METHODS Rats
Inbred LEW.1WR1, LEW.1W and LEW.1A rats were obtained from BRM, (Worcester, MA, USA). As depicted in Figure 1 , LEW.1WR1 (RT1-A u , B/D u , C a ) is an MHC-recombinant congenic strain derived from LEW.1W (RT1 u ) and LEW.1A (RT1 a ) rats. 53 RT1-A and RT1-C are Class I and Class 1b MHC genes in the rat, respectively. All of these share the diabetes susceptibility allele of Iddm14 (Tcrb-V13S1A1) 54 (Iddm14 was formerly designated Iddm4). Congenic WF.Iddm4 rats (RT1 u ) were developed and maintained at the University of Massachusetts Medical School; they express the diabetessusceptible allele of Iddm14 but are resistant to KRV þ poly I:C-induced diabetes. 54 Rats of both sexes were used in roughly equal numbers and were approximately 4-weeks-old at the time of experimentation. Animals were housed in viral antibody-free conditions, confirmed monthly to be serologically free of rat pathogens 54 and maintained in accordance with institutional (University of Massachusetts School of Medicine Institutional Animal Care and Use Committee) and national guidelines. 55 
Diabetes induction
Rats were injected with poly I:C (1 mg g À 1 body weight) three times (on days -3, -2 and -1) and then inoculated with 10 7 plaque forming units of KRV. This dose of poly I:C is not itself diabetogenic, but increases the penetrance of virus-induced diabetes in susceptible rats from B40% to up to 100%. Rats were monitored for glycosuria three times weekly; diabetes in glycosuric rats was diagnosed on the basis of blood glucose concentration 4250 mg dl À 1 on consecutive days using a hand held glucose meter (One Touch Ultra, LifeScan Inc., Milpitas, CA, USA). Animals were killed when diabetes was diagnosed or on day 40 after viral infection. Liver, pancreatic draining lymph nodes, spleens and pancreata were harvested for further analysis.
Genotyping
Genomic DNA was isolated from tail and liver samples using GenElute Mammalian Genomic DNA miniprep kit (Sigma-Aldrich, St Louis, MO, USA) and analyzed as in our previous publications. 27, 28, 56 Sequencing Genes of interest were amplified from genomic DNA of both diabetessusceptible and resistant rats using hi-fidelity taq polymerase. The PCR products were purified and sequenced by Genewiz (South Plainfield, NJ, USA). The sequences were analyzed by 4peaks software (http:// nucleobytes.com/index.php/4peaks) and aligned by CLUSTALW (http:// www.genome.jp/tools/clustalw/).
Quantitative real-time PCR (qRT-PCR)
Rats were treated to induce diabetes as above. Pancreas, pancreatic lymph nodes and spleen were harvested for RNA isolation (Ultraspec, Biotecx and RNeasy RNA kit (Qiagen, Valencia, CA, USA)) on day 0, 3 and 5. cDNA was prepared from total RNA using the ABI High capacity cDNA RT Kit (Life Technologies, Grand Island, NY, USA). PCR was carried out using Applied Biosystems SYBR Green PCR mix and the Perkin Elmer/Applied Biosystems Division 7900HT Sequence Detector (Applied Biosystems, Foster City, CA, USA), using the same samples for which global gene expression analyses were done (below).
GeneChip analyses
Total RNA was isolated from pancreatic lymph nodes of poly I:C þ KRVtreated susceptible and resistant rats treated to induce diabetes as above on day 0, 3 and 5. RNA was DNAse-treated and assessed for quality. For comparison of global gene expression differences, RNA (B100 nanograms) was amplified/labeled (Affymetrix two-cycle cDNA synthesis kit), (Affymetrix) and then hybridized to the Affymetrix RG230 2.0 array, which interrogates 430 000 transcripts and variants, in accordance to the manufacturers' protocol. After hybridization, arrays were washed and stained with Affymetrix fluidics protocol FS450_0001 and scanned with a 7G Affymetrix GeneChip Scanner. Image data were analyzed with Affymetrix Expression Console 1.1.2 software and normalized with Robust Multichip Analysis (www.bioconductor.org) to determine signal log ratios. The statistical significance of differentially induced transcription was assessed false discovery rates using Partek Genomics Suite 6.5 (Partek, St Louis, MO, USA) and use of a nonparametric rank product test. 57 To evaluate the effect of cytokine induction, the transfected cells were grown in complete media supplemented post-transfection with one of the following human recombinant cytokines (Peprotech, Rocky Hill, NJ, USA): TNF-a (10 ng ml À 1 ), IFN-a (5 pg ml À 1 ) or IFN-b (5 pg ml À 1 ). In addition, 50 ng of a b-gal expression vector, pCMV-glo-gal, was cotransfected to assess transfection efficiency. After 48 h the luciferase activity of the pGL3 plasmid was assessed using the Bright-Glo Luciferase assay system (Promega), and compared with the b-gal activity of the pCMV-glo-gal plasmid, which was evaluated using the b-gal-Galacto-Star system (Life Technologies)). The activity of the test plasmid was normalized against the control and this was used as a measure of the promoter activity.
Generation of UBD-deficient (UBD-KO) LEW.1WR1 rats
Two ZFNs targeting the 5 0 coding region in the second exon of Ubd were designed by and purchased from Sigma Aldrich. Sigma-provided quality control tests indicated a cutting efficiency of B12%. Injections of fertilized single cell embryos from superovulated LEW.1WR1 rats and transfer to pseudopregnant females were performed by the Transgenic Animal Core Facility at the University of Massachusetts Medical School using standard procedures. To prepare high quality DNA template for in vitro transcription, each of the two paired targeting ZFN-encoding expression plasmids were transformed into DH5a and plasmid DNA was isolated using the GenElute HP endotoxin-free Plasmid Maxiprep kit (Sigma). The purified ZFNencoding expression plasmids were linearized with XbaI (New England Biolabs, Ipswich, WI, USA), extracted with phenol/chloroform/isoamyl alcohol (Sigma) and precipitated with isopropanol (Fisher Scientific, Pittsburgh, PA, USA). Messenger RNA was in vitro transcribed, capped, and polyadenylated using the MessageMAX T7 ARCA-Capped Message Transcription Kit and Poly(A) polymerase Tailing Kit (Epicentre, Madison, WI, USA). The subsequent Poly(A)-tailed ZFN mRNA was column purified with the MEGAclear kit (Ambion, Grand Island, NY, USA) before resuspension in RNAse free water. The mRNA was quantified using a NanoDrop-1000 (Fisher Scientific) and assessed for quality with an Agilent bioanalyzer (Agilent, Santa Clara, CA, USA). The two paired ZFN mRNAs were combined in a concentration of 400 mg ml À 1 in RNAse free water according to Sigma guidelines. For pronuclear injection, the paired mRNAs were diluted to a final concentration of 2 ng ml À 1 in 1 mM Tris HCl, 0.1 mM EDTA and kept on ice during the microinjection procedure. One hundred fertilized 1 cell stage LEW.1WR1 embryos were micro-injected with ZFN mRNA into the male pronucleus under standard conditions. The surviving embryos were implanted into pseudopregnant Sprague Dawley female rats and allowed to develop to full term. To assess for mutants, Ubd genespecific primers were used on genomic DNA to amplify the region by PCR (Supplementary Table 1 ). We also subcloned these amplicons into pUC19 for sequence confirmation by Genewiz. Once mutant rats were identified, heterozygous LEW.1WR1 founder rats were bred to produce homozygous gene knockout animals (Supplementary Figure 1 shows the deleted target region for the UBD-KO).
